This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma
Clinical trial NCT06427213 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06427213
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2027-12-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.